Accueil Livres eBooks Revues spécialisées Références et comptes rendus Auteurs, éditeurs, examinateurs Index A-Z des produits Récompenses
Critical Reviews™ in Oncogenesis

ISSN Imprimer: 0893-9675
ISSN En ligne: 2162-6448

Volume 21, 2016

Volume 20, 2015

Volume 19, 2014

Volume 18, 2013

Volume 17, 2012

Volume 16, 2011

Volume 15, 2009

Volume 14, 2008

Volume 13, 2007

Volume 12, 2006

Volume 11, 2000

Volume 9, 1998

Volume 8, 1997

Volume 7, 1996

Volume 6, 1995

Volume 5, 1994

Numéro 1

Numéro 2-3

Numéro 4

Numéro 5

Critical Reviews™ in Oncogenesis

Editor-in-Chief: Benjamin Bonavida

Objectifs et champs d'application

The primary objective of the Critical Reviews in Oncogenesis (CRO) is the update and dissemination of scientific and clinical knowledge pertaining to the underlying molecular bases of oncogenesis by emphasizing both the journal's originality and scientific merit. CRO is dedicated to publishing timely critical reviews on topics of current interests with emphases on basic, molecular and translational applications in the field of oncogenesis. Further emphasis is focused on the roles of oncogenesis in the development of cancer and malignancies and cancer stem cells and their oncogenic potential. Reviews also consider the role of oncogenes as diagnostic biomarkers and therapeutic targets. Hence, CRO publishes special thematic issues on the above described topics and emphasizes multidisciplinary approaches.
In contrast to reviews in several other publications, CRO is highly focused on a specific and a unique thematic approach for each issue, edited by invited Editor(s), with contributions by various experts. This multidisciplinary approach for a coherent theme in Oncogenesis distinguishes CRO from many other review journal in which individual reviews that are not always interrelated, are often published. The unique Aims and Scope of CRO will lead to a wide readership and will be used as an essential reference for research scientists, clinicians, students, health professionals, and biopharmaceutical industries.

La plupart des articles téléchargés

Pediatric Rhabdomyosarcoma
Jack F. Shern, Marielle E. Yohe, Javed Khan

Src Kinase Inhibitors: Promising Cancer Therapeutics?
Helen Creedon , Valerie G . Brunton

Biology and Treatment of Rhabdoid Tumor
James I. Geller, Jacquelyn J. Roth, Jaclyn A. Biegel

Anoikis and EMT: Lethal "Liaisons" during Cancer Progression
Zheng Cao, Theodore Livas, Natasha Kyprianou

The IAP Protein Family, SMAC Mimetics and Cancer Treatment
Alex Philchenkov, Koh Miura

Johannes Hubertus Schulte, Angelika Eggert